consent

Thank you for coming to the Gilead Sciences Consent and Preference Portal

Please submit the form below to update your marketing communication consent preferences

First Name:

Last Name:

Business Email Address: Confirm Business Email Address:

If you want to opt-out, leave permissions sliders as they are below.

All Opt-in:

Relevant Product Information:

(e.g. Latest prescribing guidance, relevant clinical publications, patient information booklets and product promotional material)

Medical Education:

(e.g. CME accredited programmes both local and international, small peer meetings and hospital meetings)

Congresses:

(e.g. Educational events at both local and international congress, symposia information and sponsored places)

Industry News:

(e.g. Updates on corporate information, changes within the industry, relevant NHS and therapy area news)

I accept the terms and conditions below

By clicking on submit below, you are informing Gilead Sciences Ltd of your preferences for marketing communications. If you are opting out of receiving such information, you will not be sent any relevant applicable communications through electronic means, although Gilead may still send you by electronic means important product safety updates when required to do so by regulatory authorities or other statutory bodies.

Where you opt in, you are consenting to receive relevant marketing communications from Gilead Sciences Ltd (and/or its affiliates) by electronic means (such as email or SMS). Gilead Sciences Ltd may share your personal data with other Gilead affiliates and or third party vendors who provide services to Gilead for the purposes of providing you with that information you have agreed to receive, or a means by which you can provide your communication preferences to Gilead. Gilead shall remain responsible for the confidentiality and security of your personal data at all times.

By law, Gilead is required to obtain your consent in order to be able to send such electronic communications to you. We encourage you to read our Privacy Statement for further information about how Gilead will process your data and what your rights are in relation to that processing. for further information about how Gilead will process your data and what your rights are in relation to that processing.

You have the right to opt-out of receiving such electronic communications, at any time, by contacting us or clicking the unsubscribe or preference centre links at the bottom of our emails to you.

This is a promotional website designed, built and funded by Kite, a Gilead Company

This website is intended for healthcare professionals in Saudi Arabia. It contains promotional information about Gilead Pharmaceutical Products, educational material on therapy areas and professional resources.

I am a healthcare professional

I am a non healthcare professional

If you would like more information please visit www.gilead.com

Reporting suspected adverse reactions of medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the National Pharmacovigilance Centre (NPC): Unified number: 19999 or email: [email protected]
Adverse reactions may also be reported directly to Gilead.
Adverse reactions related to Gilead products may be reported directly to Gilead via [email protected]

Veeva Code:SA-YES-0066

Date of preparation: April 2023

You have successfully logged out.